Coala Life completes $10M in investment capital, will open the US market.
Summary
Coala Life, a Stockholm, Sweden-based medical technology company, announced securing a SEK 92M ($10M) capital investment round. The money was provided by about 40 Swedish institutional and private investors, including 20 North Street, Larry Leksell, Anders Nyrén as well as founders and management. The Board of Directors is chaired by Liselott Kilaas, formerly President and CEO of Aleris and includes Anders Nyrén, Sören Olofsson, Ebba Fåhraeus and Johanna Öberg. Coala Life, founded in 2004 and led by CEO Philip Siberg, built a portfolio of products focused on cardiac diagnostics and digital health. The products, the Coala Heart Monitor and the Coala Heart Monitor Pro, enable patient and user-centered cardiac examinations – based on smart algorithms, adhesive-free and cloud connected sensors and without restrictions in use and time.